Visit: 60 Corporate Woods, Suite 380 | Email: URVenturesInfo@urmc.rochester.edu | Phone: 585-276-6600
May 27, 2020 Lindsey Valich / lvalich@ur.rochester.edu A person who has a stroke that causes vision loss is often told there is nothing they can do to improve or regain the vision they have lost. But research from the University of Rochester, published in the journal Brain, may
Once again, the University of Rochester ranked among the top 100 worldwide universities granted U.S. utility patents in 2019, according to a report by the National Academy of Inventors (NAI) and the Intellectual Property Owners Association (IPO). Published annually since 2013, the report ranks the
Given the changing circumstances due to the Covid-19 pandemic, URVentures has decided to cancel the Spring 2020 round of the Technology Development Fund. Please direct any questions to the Fund’s Director. Omar Bakht Fund Director Omar_Bakht@urmc.rochester.edu
CNY Biotech Accelerator, a division of the State University of New York Upstate Medical University, located in Syracuse, NY, is seeking medical device innovators for its annual 6-month grant-funded Medical Device Innovation Challenge (MDIC). Applications from US-based innovators are accepted January 1 – May 31,
A new needle-free flu vaccine patch revved up the immune system much like a traditional flu shot without any negative side effects, according to a study published in the Journal of Investigative Dermatology. Though the research is in the early stages (the patch hasn’t been tested in
Oscine Therapeutics, a new biotechnology company based on discoveries made and developed at the University of Rochester Medical Center (URMC) has received a significant multi-year investment to support both research and development of cell-based therapies for neurological disorders. The funding represents the largest-ever investment in
University of Rochester start-up, VPG Medical, was recently featured in the Rochester Business Journal: VPG Medical uses unconventional tech for heart care Among the companies in the Luminate NY accelerator, VPG Medical Inc. is a bit unique. While most companies in the accelerator are based
Precision medicine is saving lives, but Harris A. (Handy) Gelbard, director of Center for Neurotherapeutics Discovery at URMC, believes we’re overlooking another class of extremely important treatment candidates: multi-target drugs. In STAT News, he shares his views on why U.S.-based pharmaceutical companies should pay closer attention
Learning a musical instrument requires dedication, practice, and time. Making performance errors is a natural part of the learning process; however, learning delays can occur when errors go uncorrected during individual practice. A recently established startup company, Shenzhen Mango Future Education Technology Co (Mango Future),
Rochester-based Health Care Originals (HCO), is a leading digital health startup, integrating IoT technologies to empower everyone through improved understanding and management of their health and medical conditions. HCO’s current wearable solutions are optimized for respiratory system applications, providing revolutionary, actionable insight into illnesses like
The groundbreaking work of three scholars with ties to the University of Rochester took center stage when pioneering laser scientist Donna Strickland ’89 (PhD) and her Rochester advisor Gerard Mourou formally received the Nobel Prize in Physics, and Paul Romer, whose early career tenure-track appointment
Health Care Originals, a leading digital health startup commercializing patented University of Rochester technology, announced that former Chief Executive Officer of University of Rochester Medical Center, Dr. Bradford Berk, has joined its Board of Directors. Read more.
Koning Corporation’s breast computed tomography (KCBT 1000) system was nominated for Best Medical Technology at the 12th annual Prix Galien awards. The Prix Galien awards recognize outstanding achievements in improving the human condition through the development of innovative therapies. Worldwide, the Prix Galien is regarded
The Technology Development Fund (TDF) made four awards in the latest round. Awards ranged from $50,000 – $100,000 for projects of one-year in length. Interested to learn more about the projects funded in this round? Contact us. Fiber Array to Silicon Photonic Chip Optical Packaging Jaime
Five projects received Drug Development Pilot Awards in the latest round: Development of UR214-7 and UR214-9 for cancer treatments Kyu Kwang Kim, Department of Obstetrics and Gynecology Small Molecule Modulators of U2AF-Dependent Splicing in Myelodysplastic Syndromes Clara L. Kielkopf, Department of Biochemistry and Biophysics Innate